Aequus Announces Issuance of Stock Options
August 26, 2020 08:15 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus Announces New Chief Commercial Officer
August 20, 2020 08:30 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus Announces Issuance of Stock Options
June 04, 2020 22:30 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, June 04, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Amendment on Earlier Release: Aequus Provides General Update and First Quarter 2020 Financial Highlights
June 01, 2020 15:12 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, June 01, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus Provides General Update and First Quarter 2020 Financial Highlights
June 01, 2020 09:15 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, June 01, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus Provides General Update and 2019 Financial Highlights
April 29, 2020 21:00 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, April 29, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus Announces Positive Update on Dry Eye Product Launch Plans
April 21, 2020 11:00 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, April 21, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
A Message from the CEO of Aequus Pharmaceuticals
March 23, 2020 08:45 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, March 23, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus Announces Appointment of New Director to its Board & Stock Option Grant
February 19, 2020 09:20 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus and Medicom Announce Changes to their Respective Commercial Leadership Teams
February 03, 2020 09:15 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...